Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Augusto Miravalle

Concepts (87)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
9
2021
372
1.270
Why?
Immunosuppressive Agents
5
2021
641
1.190
Why?
Multiple Sclerosis, Relapsing-Remitting
5
2021
69
1.160
Why?
Nervous System Diseases
3
2015
254
1.040
Why?
Cladribine
1
2021
2
0.740
Why?
Vaccines
2
2014
375
0.550
Why?
Encephalomyelitis, Acute Disseminated
2
2009
13
0.550
Why?
Demyelinating Diseases
2
2019
73
0.540
Why?
Clinical Coding
1
2016
19
0.530
Why?
Office Visits
1
2016
79
0.520
Why?
International Classification of Diseases
1
2016
116
0.500
Why?
Immunologic Factors
5
2020
217
0.470
Why?
Immune Reconstitution Inflammatory Syndrome
2
2012
18
0.460
Why?
Vaccination
2
2014
1202
0.450
Why?
Natalizumab
6
2021
46
0.440
Why?
4-Aminopyridine
1
2011
21
0.370
Why?
Gait Disorders, Neurologic
1
2011
41
0.360
Why?
Managed Care Programs
1
2011
133
0.350
Why?
Antibodies, Monoclonal
3
2010
1257
0.340
Why?
Benchmarking
1
2011
161
0.340
Why?
Yellow Fever Vaccine
1
2009
6
0.330
Why?
Multiple Sclerosis, Chronic Progressive
2
2021
25
0.310
Why?
Telemedicine
1
2016
662
0.300
Why?
Leukoencephalopathy, Progressive Multifocal
2
2020
38
0.270
Why?
Antibodies, Monoclonal, Humanized
4
2012
660
0.220
Why?
Smallpox Vaccine
1
2003
22
0.220
Why?
Quality of Life
5
2021
2343
0.190
Why?
Transcranial Direct Current Stimulation
1
2021
4
0.190
Why?
Clinical Trials, Phase IV as Topic
1
2021
3
0.190
Why?
Tablets
1
2021
36
0.180
Why?
Glatiramer Acetate
2
2019
20
0.180
Why?
Motor Disorders
1
2021
17
0.180
Why?
Observational Studies as Topic
1
2021
90
0.180
Why?
JC Virus
1
2020
23
0.170
Why?
Rituximab
2
2019
148
0.170
Why?
Cerebellar Diseases
1
2020
21
0.170
Why?
Multicenter Studies as Topic
1
2021
249
0.170
Why?
Capsid Proteins
1
2020
68
0.170
Why?
Administration, Oral
1
2021
725
0.150
Why?
Humans
19
2021
114045
0.150
Why?
Magnetic Resonance Imaging
5
2021
3039
0.130
Why?
Phosphodiesterase Inhibitors
1
2016
82
0.130
Why?
Brain
6
2021
2355
0.130
Why?
Prospective Studies
2
2021
6195
0.120
Why?
Bacterial Vaccines
1
2014
61
0.110
Why?
Pyridines
1
2016
419
0.100
Why?
Viral Vaccines
1
2014
88
0.100
Why?
Adjuvants, Immunologic
1
2014
206
0.100
Why?
Autoimmune Diseases
1
2015
381
0.100
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
82
0.090
Why?
Mobility Limitation
1
2011
60
0.090
Why?
Nerve Regeneration
1
2010
50
0.090
Why?
Autoimmunity
1
2015
812
0.080
Why?
Secondary Prevention
1
2010
221
0.080
Why?
Disease Progression
2
2016
2371
0.080
Why?
Male
4
2021
55396
0.070
Why?
Peptides
1
2011
847
0.060
Why?
Female
5
2021
59324
0.060
Why?
Practice Guidelines as Topic
1
2011
1381
0.050
Why?
Age Factors
1
2010
2885
0.050
Why?
Double-Blind Method
2
2019
1656
0.050
Why?
Adult
5
2021
30375
0.050
Why?
Severity of Illness Index
1
2010
2537
0.050
Why?
Middle Aged
4
2021
26605
0.050
Why?
Neurophysiology
1
2021
13
0.050
Why?
Atrophy
1
2021
152
0.050
Why?
Young Adult
2
2021
10444
0.050
Why?
Transcranial Magnetic Stimulation
1
2021
44
0.040
Why?
Biomarkers
1
2010
3397
0.040
Why?
Treatment Outcome
2
2011
9049
0.040
Why?
Time Factors
1
2010
6077
0.040
Why?
Animals
3
2014
31565
0.040
Why?
Maintenance Chemotherapy
1
2019
22
0.040
Why?
Induction Chemotherapy
1
2019
56
0.040
Why?
Lower Extremity
1
2021
334
0.040
Why?
Risk Factors
1
2010
8614
0.040
Why?
Incidence
1
2003
2314
0.030
Why?
Diffusion Tensor Imaging
1
2016
63
0.030
Why?
B-Lymphocytes
2
2011
762
0.030
Why?
United States
1
2011
12137
0.030
Why?
Maximum Tolerated Dose
1
2011
183
0.020
Why?
Research Design
1
2016
919
0.020
Why?
Dendritic Cells
1
2011
435
0.020
Why?
CD8-Positive T-Lymphocytes
1
2012
686
0.020
Why?
T-Lymphocytes
1
2011
1735
0.010
Why?
Adolescent
1
2021
17800
0.010
Why?
Aged
1
2020
18969
0.010
Why?
Miravalle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)